TITLE

Licensing News Headlines September 15, 2003 - October 14, 2003

PUB. DATE
November 2003
SOURCE
PharmaWatch: Biotechnology;November 2003, Vol. 2 Issue 11, p21
SOURCE TYPE
Market Research Report
DOC. TYPE
Article
ABSTRACT
Reports developments related to contracts in the biotechnology sector from September 2003 to October 2003. Collaboration between Acambis PLC and George Mason University; Termination of the partnership between AstraZeneca PLC and NicOx SA; Acquisition of the anticancer drug from Lorus Therapeutics Inc. by Cyclacel Ltd.
ACCESSION #
13838902

 

Related Articles

  • Cyclacel acquires novel anticancer drug from Lorus Therapeutics.  // PharmaWatch: Biotechnology;November 2003, Vol. 2 Issue 11, p22 

    Reports on the acquisition of the anticancer drug CYC381 from the biotechnology firm Lorus Therapeutics Inc. by Cyclacel Ltd. Ability of the drug to arrest cancer cells; Terms of the agreement; Payment received by Lorus from the agreement.

  • NICOX TO REACQUIRE RIGHTS TO ASTRAZENICA CINOD DRUGS.  // Biotech Business;Nov2003, Vol. 16 Issue 11, p7 

    Reports on the reacquisition of full rights to the proprietary class of anti-inflammatory and analgesic compounds, CINOD, from AstraZeneca PLC by NicOx SA as of November 2003.

  • AstraZeneca pulls out of collaboration with NicOx.  // PharmaWatch: Biotechnology;November 2003, Vol. 2 Issue 11, p22 

    Reports on the termination of the collaboration between the biotechnology firms AstraZeneca PLC and NicOx SA. Acquisition of rights to anti-inflammatory and analgesic compounds by NicOx; Disagreement between the firms; Search of new partners by NicOx.

  • Biotechnology Industry Profile: United Kingdom.  // Biotechnology Industry Profile: United Kingdom;Jul2009, p1 

    Presents a profile of the Biotechnology industry in the United Kingdom. Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the industry; Market forecasts; Demographics; Further reading.

  • Biotechnology Industry Profile: United Kingdom.  // Biotechnology Industry Profile: United Kingdom;Aug2008, p1 

    Presents a profile of the Biotechnology industry in the United Kingdom. Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the industry; Market forecasts; Demographics; Further reading.

  • FINANCINGS ROUNDUP.  // BioWorld Today;6/7/2010, Vol. 21 Issue 108, p6 

    This section offers news briefs concerning finances of biotechnology companies, which include the repurchase of outstanding common stock by BioSpecifics Technologies Corp. and the filing of a registration statement by Lorus Therapeutics Inc.

  • Financings Roundup.  // BioWorld Today;11/11/2010, Vol. 21 Issue 219, p4 

    The article presents an update on the financing efforts of several biotechnology companies as of November 11, 2010, including Biodesix Inc., Cerus Corp. and Lorus Therapeutics Inc.

  • Dundee U's Academic/Industry Partnership Extended to 2016. Moran, Nuala // BioWorld Today;3/14/2012, Vol. 23 Issue 40, p1 

    The article reports on the renewal by Dundee University of its partnership agreement with some pharmaceutical firms on protein phosphorylation and kinase enzymes research. The research program will be extended until 2016 and will focus on protein ubiquitylation. Dundee University partners...

  • Acambis to work with George Mason University on HIV study.  // PharmaWatch: Biotechnology;November 2003, Vol. 2 Issue 11, p21 

    Reports on the collaboration between Acambis PLC and George Mason University for an HIV research. Findings of the university on the role of smallpox vaccine in preventing the contraction of HIV; Optimism of scientists about the potential applications of results; Possibility for the development...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics